Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
EF English Proficiency Index 2025 launched: AI-Powered Insights Reveal Global Language Shifts in a Fragmented World
Skills gap widespread; gender gap narrowing; youth proficiency low ZURICH, Nov. 19,…
Advanced CAR-T Cell Therapy in a Young Engineer Battling High-Risk Pre-B Acute Lymphoblastic Leukemia
KOLKATA, India, Sept. 25, 2025 /PRNewswire/ -- In a major milestone for…